EMBECTA CORP (EMBC)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for EMBC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| EMBC | Chair; President of the Albert and Mary Lasker Foundation | 70 | ["expert in infectious diseases", "broad experience in healthcare delivery", "health system administration", "payer and medical reimbursement", "higher education", "medical research", "public health", "perspectives on patient care services", "global health", "health policy"] | ["Corporate Governance and Nominating", "Technology, Quality and Regulatory"] | 2025 |
Biography sourced from the proxy statement filing.
President, The Albert and Mary Lasker Foundation
Age: 70
Director Since: 2022
Independent: Yes
Committees: Corporate Governance and Nominating (Chair), Technology, Quality and Regulatory
Other Public Directorships: Haemonetics Corporation
Former Public Directorships (last 5 years): Becton, Dickinson and Company
Dr. Pomeroy has served since 2013 as President of the Albert and Mary Lasker Foundation, a private foundation that seeks to improve health by accelerating support for medical research through recognition of research excellence, public education and advocacy. Prior thereto, she served as Dean and Vice Chancellor of the University of California, Davis School of Medicine. She is an elected member of the National Academy of Medicine.
Dr. Pomeroy is a member of the Board of Directors of Haemonetics Corporation (NYSE: HAE). Dr. Pomeroy also serves on the Board of Directors of the Sierra Health Foundation, Center for Women in Academic Medicine and Science, Science Communication Lab, Science Philanthropy Alliance, Research!America, Geisinger School of Medicine, and Morehouse School of Medicine.
Education:
Dr. Pomeroy holds a Bachelor's degree in Biomedical Sciences and Doctor of Medicine (M.D.) from the University of Michigan, as well as a Master of Business Administration from the University of Kentucky.
Qualifications, Skills and Experience:
Dr. Pomeroy is an expert in infectious diseases, with broad experience in areas of healthcare delivery, health system administration, payer and medical reimbursement, higher education, medical research and public health. She brings to the Board important perspectives on patient care services, global health and health policy.